Literature DB >> 17367288

Adverse late effects of childhood cancer and its treatment on health and performance.

Kirsten K Ness1, James G Gurney.   

Abstract

More than 12,000 newly diagnosed cases of cancer occur each year in the United States among children ages 20 years or younger, and the current 5-year survival rate is near 80%. An estimated 228,000 among adults 47 years or younger and currently living in the United States had a diagnosis of cancer during childhood or adolescence. Here, we review long-term adverse effects of childhood cancer and its treatment with an emphasis on physical performance and health. We also briefly review existing guidelines that may be used to develop appropriate exercise and diet interventions for childhood cancer survivors. We suggest that there is a need for development of evidence-based, risk-based guidelines and interventions for health promotion among long-term childhood cancer survivors, particularly for those whose physical activity limitations interfere with chances for optimizing their bodies' potential in today's society.

Entities:  

Mesh:

Year:  2007        PMID: 17367288     DOI: 10.1146/annurev.publhealth.28.021406.144049

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  25 in total

1.  Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory ™ generic core scales, cancer module, and multidimensional fatigue scale in long-term adult survivors of pediatric cancer.

Authors:  Rhonda S Robert; Raheem J Paxton; Shana L Palla; Grace Yang; Martha A Askins; Shaini E Joy; Joann L Ater
Journal:  Pediatr Blood Cancer       Date:  2012-02-02       Impact factor: 3.167

2.  The perceived impact of cancer on quality of life for post-treatment survivors of childhood cancer.

Authors:  Brad J Zebrack; Wendy Landier
Journal:  Qual Life Res       Date:  2011-03-31       Impact factor: 4.147

3.  Smoking behavior among adult childhood cancer survivors: what are we missing?

Authors:  Taghrid Asfar; Noella A Dietz; Kristopher L Arheart; Stacey L Tannenbaum; Laura A McClure; Lora E Fleming; David J Lee
Journal:  J Cancer Surviv       Date:  2015-06-02       Impact factor: 4.442

4.  Physical Rehabilitation Practices for Children and Adolescents with Cancer in Canada.

Authors:  Paula A Ospina; Lesley Wiart; David D Eisenstat; Margaret L McNeely
Journal:  Physiother Can       Date:  2020       Impact factor: 1.037

5.  Emotional distress among adult survivors of childhood cancer.

Authors:  S Cristina Oancea; Tara M Brinkman; Kirsten K Ness; Kevin R Krull; Webb A Smith; D Kumar Srivastava; Leslie L Robison; Melissa M Hudson; James G Gurney
Journal:  J Cancer Surviv       Date:  2014-01-24       Impact factor: 4.442

6.  Constraint-Induced Movement Therapy for Children With Brain Tumors.

Authors:  Jessica Sparrow; Liang Zhu; Amar Gajjar; Belinda N Mandrell; Kirsten K Ness
Journal:  Pediatr Phys Ther       Date:  2017-01       Impact factor: 3.049

7.  Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group.

Authors:  Catherine Fiona Macpherson; Mary C Hooke; Debra L Friedman; Kristin Campbell; Janice Withycombe; Cindy L Schwartz; Kara Kelly; Jane Meza
Journal:  J Adolesc Young Adult Oncol       Date:  2015-09       Impact factor: 2.223

8.  Living with the cerebellar mutism syndrome: long-term challenges of the diagnosis.

Authors:  Morten Wibroe; Marianne Vie Ingersgaard; Hanne Bækgaard Larsen; Marianne Juhler; Karin Piil
Journal:  Acta Neurochir (Wien)       Date:  2020-07-03       Impact factor: 2.216

9.  Deficits in physical function among young childhood cancer survivors.

Authors:  Megan C Hoffman; Daniel A Mulrooney; Julia Steinberger; Jill Lee; K Scott Baker; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

Review 10.  Social outcomes in the Childhood Cancer Survivor Study cohort.

Authors:  James G Gurney; Kevin R Krull; Nina Kadan-Lottick; H Stacy Nicholson; Paul C Nathan; Brad Zebrack; Jean M Tersak; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.